EC Number   |
Inhibitors |
Structure |
|---|
    2.8.2.33 | (1R,3R,4S)-menthyl 2-acetamido-2-deoxy-4-O-sulfonato-beta-D-galactopyranoside |
- |
   |
| 2.8.2.33 | (1S,3S,4R)-menthyl 2-acetamido-2-deoxy-4-O-sulfonato-beta-D-galactopyranoside |
weak inhibition |
|
| 2.8.2.33 | 1-naphthyl 2-acetamido-2-deoxy-4-O-sulfonato-beta-D-galactopyranoside |
- |
|
| 2.8.2.33 | 17beta-hydroxyestra-1,3,5(10)-trien-3-yl 2-acetamido-2-deoxy-4-O-sulfonato-beta-D-galactopyranoside |
competitive inhibitor, 40% inhibition at 0.05 mM, nearly complete inhibition at 0.25 mM |
|
| 2.8.2.33 | 3-hydroxyestra-1,3,5(10)-trien-17beta-yl 2-acetamido-2-deoxy-4-O-sulfonato-beta-D-galactopyranoside |
- |
|
| 2.8.2.33 | 4-chlorophenyl 2-acetamido-2-deoxy-4-O-sulfonato-beta-D-galactopyranoside |
- |
|
| 2.8.2.33 | 4-fluorophenyl 2-acetamido-2-deoxy-4-O-sulfonato-beta-D-galactopyranoside |
- |
|
| 2.8.2.33 | 4-nitrophenyl 2-acetamido-2-deoxy-4-O-sulfonato-beta-D-galactopyranoside |
- |
|
| 2.8.2.33 | benzyl 2-acetamido-2-deoxy-4-O-sulfonato-beta-D-galactopyranoside |
- |
|
| 2.8.2.33 | beta-O-phenyl-GalNAc(4SO4) |
inhibition of the enzyme in vitro |
|
